Product image of Linezolid Accord (Linezolid) supplied by GNH India

Linezolid Accord

Active Ingredient:
Linezolid
Origin:
EU

Linezolid Accord (Linezolid)

Linezolid, the active ingredient in Linezolid Accord, is an oxazolidinone presented as a sterile injection for intravenous use. It is indicated for the treatment of serious bacterial infections, including skin and soft tissue infections, community‑acquired bacterial pneumonia, and nosocomial pneumonia, primarily in adult patients.

GNH India supplies Linezolid Accord as a licensed, GDP‑compliant international pharmaceutical product, providing reliable access to hospitals, pharmacies and clinics worldwide. The injection conforms to EU regulatory standards and is sourced from approved manufacturing facilities.

Manufacturer / TM Owner

Accord Healthcare B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Linezolid is an oxazolidinone antibiotic used to treat infections caused by Gram‑positive bacteria.

  • Skin and soft tissue infections: effective against MRSA and other resistant Gram‑positive pathogens, leading to clinical cure.
  • Community‑acquired bacterial pneumonia: provides bacterial eradication and improvement of respiratory symptoms.
  • Nosocomial pneumonia: used for hospital‑acquired pneumonia caused by susceptible organisms, reducing mortality risk.

How It Works

  • Linezolid binds to the 50S ribosomal subunit of susceptible bacteria, preventing the formation of the initiation complex required for protein synthesis. This inhibition halts bacterial growth, rendering the organism unable to proliferate and allowing the host immune system to clear the infection.

Side Effects

Linezolid may cause a range of adverse reactions, from mild to serious.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Diarrhea: loose stools, often self‑limiting.
  • Headache: transient cranial discomfort.
  • Vomiting: occasional emesis.
  • Metallic taste: altered taste perception.
  • Rash: mild skin erythema.

Serious or Rare Side Effects

  • Thrombocytopenia: significant drop in platelet count, requiring monitoring.
  • Anemia: reduction in red blood cell count, potentially leading to fatigue.
  • Peripheral neuropathy: nerve damage causing tingling or numbness.
  • Serotonin syndrome: risk when combined with serotonergic agents.
  • Lactic acidosis: rare metabolic disturbance.
  • Optic neuritis: vision changes requiring urgent assessment.

Precautions & Warnings

Before initiating therapy, consider patient‑specific factors and monitor appropriately.

  • Renal impairment: adjust therapy based on renal function and monitor serum creatinine.
  • Hepatic impairment: monitor liver enzymes during treatment.
  • Concurrent MAO inhibitors: avoid due to risk of serotonin syndrome.
  • Long‑term therapy (>2 weeks): regularly monitor complete blood counts.
  • Pregnancy and lactation: use only if benefits outweigh potential risks.
  • Store at 2‑8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Linezolid interacts with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid)

  • SSRIs and SNRIs: risk of serotonin syndrome.
  • MAO inhibitors: risk of serotonin syndrome.
  • Rifampicin: significant reduction in linezolid exposure.

Moderate Interactions (Monitor Closely)

  • Warfarin: may increase anticoagulant effect; monitor INR.
  • NSAIDs: increased bleeding risk; observe for gastrointestinal events.

Frequently Asked Questions

Linezolid Accord is an intravenous formulation of the oxazolidinone antibiotic linezolid. It is prescribed for serious Gram‑positive bacterial infections such as skin and soft tissue infections, community‑acquired bacterial pneumonia, and hospital‑acquired (nosocomial) pneumonia in adult patients.

Linezolid inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. This prevents the formation of the initiation complex needed for translation, halting bacterial growth and allowing the immune system to eliminate the infection.

The exact dose and duration of Linezolid Accord are determined by the prescribing clinician based on the infection type, severity, patient weight, renal and hepatic function, and local antimicrobial guidelines.

The pregnancy category for linezolid is listed as unknown. Use during pregnancy or lactation only if the potential benefit justifies the potential risk to the fetus or infant, and after careful evaluation by the treating physician.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where applicable) and necessary import documentation.

Linezolid offers oral and intravenous options and is active against many resistant Gram‑positive organisms, including MRSA and VRE. Compared with vancomycin, it provides similar efficacy for skin infections and pneumonia but does not require therapeutic drug monitoring and has a different safety profile, especially regarding nephrotoxicity.

Linezolid Accord should be stored at 2‑8 °C (refrigerated). Keep the vials in their original packaging, protect from light, and avoid freezing or shaking the product to maintain stability.

The product is supplied as a sterile powder for injection. It must be reconstituted with the appropriate diluent, then administered intravenously over a recommended infusion period, typically 30–60 minutes, under aseptic conditions.

Serious adverse events include thrombocytopenia, anemia, peripheral neuropathy, optic neuritis, lactic acidosis, and serotonin syndrome, especially when combined with serotonergic drugs. Patients should be monitored regularly for blood‑count changes and neurological symptoms.

Linezolid Accord is contraindicated in patients with known hypersensitivity to linezolid or any component of the formulation. It should also be avoided in individuals currently receiving monoamine oxidase inhibitors or those with uncontrolled hypertension when combined with tyramine‑rich foods.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Linezolid

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT